📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Reply to: Oligoclonality of TRBC1 and TRBC2 in T cell lymphomas as mechanism of primary resistance to TRBC-directed CAR T cell therapies. (2025)

First Author: Ferrari M

Attributed to: Comprehensive analysis of T-cell receptor degeneracy and T-cell crossreactivity funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41467-025-56396-7

PubMed Identifier: 39880830

Publication URI: http://europepmc.org/abstract/MED/39880830

Type: Journal Article/Review

Volume: 16

Parent Publication: Nature communications

Issue: 1

ISSN: 2041-1723